Optimization and Evaluation of the In Vitro Permeation Parameters of Topical Products with Non-Steroidal Anti-Inflammatory Drugs through Strat-M

Plackett–Burman design Strat-M® membrane diclofenac etofenamate ibuprofen in vitro permeation test ketoprofen naproxen

Journal

Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003

Informations de publication

Date de publication:
20 Aug 2021
Historique:
received: 30 06 2021
revised: 12 08 2021
accepted: 17 08 2021
entrez: 28 8 2021
pubmed: 29 8 2021
medline: 29 8 2021
Statut: epublish

Résumé

Pharmaceutical products containing non-steroidal anti-inflammatory drugs (NSAIDs) are among the most prescribed topical formulations used for analgesic and antirheumatic properties. These drugs must overcome the skin barrier to cause a therapeutic effect. Human skin has been widely used as a model to study in vitro drug diffusion and permeation, however, it suffers from many limitations. Therefore, to perform in vitro permeation test (IVPT), we used a Strat-M

Identifiants

pubmed: 34452264
pii: pharmaceutics13081305
doi: 10.3390/pharmaceutics13081305
pmc: PMC8398299
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Pain Ther. 2020 Dec;9(2):393-410
pubmed: 32562238
J Pharm Sci. 2007 Apr;96(4):814-23
pubmed: 17286288
Eur J Pharm Sci. 2015 Jan 25;67:113-118
pubmed: 25447745
J Pharm Sci. 2021 Jun;110(6):2517-2523
pubmed: 33508308
Eur J Pharm Biopharm. 2014 Feb;86(2):301-6
pubmed: 24252713
Pharmaceutics. 2020 Oct 30;12(11):
pubmed: 33143093
Int J Pharm. 2001 Mar 14;215(1-2):51-6
pubmed: 11250091
J Pain Res. 2019 Apr 12;12:1149-1154
pubmed: 31114298
Semin Arthritis Rheum. 2016 Feb;45(4 Suppl):S18-21
pubmed: 26806189
Biomed Pharmacother. 2019 Mar;111:785-790
pubmed: 30612003
Skin Pharmacol Appl Skin Physiol. 2003 May-Jun;16(3):137-42
pubmed: 12677093
Int J Pharm. 2020 Aug 30;586:119572
pubmed: 32599131
Int J Pharm. 2018 Mar 25;539(1-2):58-64
pubmed: 29366943
Pharm Res. 2020 Feb 7;37(3):49
pubmed: 32034502
AAPS J. 2010 Sep;12(3):263-71
pubmed: 20373062
J Pain Res. 2020 Nov 04;13:2805-2814
pubmed: 33177865
Curr Drug Deliv. 2009 Jan;6(1):93-100
pubmed: 19418961
Sci Pharm. 2013 Jul 22;81(4):1017-28
pubmed: 24482770
Drug Dev Ind Pharm. 2002 Nov;28(10):1285-94
pubmed: 12476874
Basic Clin Pharmacol Toxicol. 2017 Nov;121(5):423-429
pubmed: 28561421
AAPS PharmSciTech. 2019 Apr 15;20(5):164
pubmed: 30993407
Pharmaceutics. 2020 Feb 13;12(2):
pubmed: 32070011
Biopharm Drug Dispos. 2019 Jul;40(7):217-224
pubmed: 31242332
J Pharm Biomed Anal. 2018 Jan 5;147:590-611
pubmed: 28579052
Pharmazie. 2013 Jul;68(7):565-71
pubmed: 23923638
AAPS PharmSciTech. 2018 May;19(4):1606-1624
pubmed: 29488196
Int J Pharm. 2018 Aug 25;547(1-2):432-437
pubmed: 29890259
Skin Res Technol. 2019 Sep;25(5):725-734
pubmed: 31062432
Int J Pharm. 2001 Aug 14;224(1-2):1-18
pubmed: 11512545
Pharmaceutics. 2020 Feb 19;12(2):
pubmed: 32092954
Eur J Pharm Sci. 2013 Dec 18;50(5):569-76
pubmed: 23474357
Pharm Dev Technol. 2016 Dec;21(8):980-989
pubmed: 26369621
J Control Release. 2001 Nov 9;77(1-2):17-25
pubmed: 11689256
AAPS PharmSciTech. 2010 Sep;11(3):1432-41
pubmed: 20842539
Pharm Dev Technol. 2015;20(6):710-5
pubmed: 24798887
Pain Med. 2010 Apr;11(4):535-49
pubmed: 20210866
Pharm Dev Technol. 2017 Jun;22(4):521-536
pubmed: 26786600
J AOAC Int. 2014 Jan-Feb;97(1):3-11
pubmed: 24672854
Br J Plast Surg. 2000 Jun;53(4):331-6
pubmed: 10876260
Eur J Pharm Biopharm. 2009 May;72(1):275-81
pubmed: 19026745
J Pharm Sci. 2015 Oct;104(10):3459-70
pubmed: 26213208
Int J Biol Macromol. 2013 Jul;58:354-9
pubmed: 23567284
Drug Dev Ind Pharm. 2019 Dec;45(12):1849-1855
pubmed: 31617433
Skin Pharmacol Physiol. 2006;19(1):17-21
pubmed: 16247245
Toxicol In Vitro. 2009 Feb;23(1):1-13
pubmed: 19013230
Pharmaceutics. 2020 Feb 13;12(2):
pubmed: 32069850
J Chromatogr B Analyt Technol Biomed Life Sci. 2012 Dec 1;910:2-13
pubmed: 22333438
Pharmaceutics. 2018 Sep 05;10(3):
pubmed: 30189634

Auteurs

Bartłomiej Milanowski (B)

Chair and Department of Pharmaceutical Technology, Poznan University of Medical Sciences, ul. Grunwaldzka 6, 60-780 Poznań, Poland.
GENERICA Pharmaceutical Lab, Regionalne Centrum Zdrowia Sp. z o. o., ul. Na Kępie 3, 64-360 Zbąszyń, Poland.

Hanna Wosicka-Frąckowiak (H)

Chair and Department of Pharmaceutical Technology, Poznan University of Medical Sciences, ul. Grunwaldzka 6, 60-780 Poznań, Poland.
GENERICA Pharmaceutical Lab, Regionalne Centrum Zdrowia Sp. z o. o., ul. Na Kępie 3, 64-360 Zbąszyń, Poland.

Eliza Główka (E)

Chair and Department of Pharmaceutical Technology, Poznan University of Medical Sciences, ul. Grunwaldzka 6, 60-780 Poznań, Poland.
GENERICA Pharmaceutical Lab, Regionalne Centrum Zdrowia Sp. z o. o., ul. Na Kępie 3, 64-360 Zbąszyń, Poland.

Małgorzata Sosnowska (M)

GENERICA Pharmaceutical Lab, Regionalne Centrum Zdrowia Sp. z o. o., ul. Na Kępie 3, 64-360 Zbąszyń, Poland.

Stanisław Woźny (S)

GENERICA Pharmaceutical Lab, Regionalne Centrum Zdrowia Sp. z o. o., ul. Na Kępie 3, 64-360 Zbąszyń, Poland.

Filip Stachowiak (F)

GENERICA Pharmaceutical Lab, Regionalne Centrum Zdrowia Sp. z o. o., ul. Na Kępie 3, 64-360 Zbąszyń, Poland.

Angelika Suchenek (A)

MYLAN Healthcare Sp. z o. o., ul. Postępu 21B, 02-676 Warszawa, Poland.

Dariusz Wilkowski (D)

MYLAN Healthcare Sp. z o. o., ul. Postępu 21B, 02-676 Warszawa, Poland.

Classifications MeSH